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ABSTRACT Primary-i.e., nonsyndromal-postlingual
deafness is inherited as an autosomal dominant phenotype in a
large kindred in Costa Rica. Genetically susceptible individuals
begin to lose hearing at low frequencies at about age 10 years,
after language and speaking are learned. Deafness inevitably
progresses by age 30 years to bilateral hearing loss of all
frequencies. Intelligence, fertility, and life expectancy are
normal. The family traces its ancestry to an affected founder
born in Costa Rica in 1754. We have mapped the gene for
deafness in this kindred to chromosome 5q31, between the
markers IL9 and GRL, by linkage analysis involving 99 infor-
mative relatives.
Human deafness is a major medical and public health con-
cern. A generation ago, most congenital deafness was attrib-
utable to viral diseases during pregnancy. Now that maternal
viral diseases are far less common, perhaps 50% of deafness
in newborns has a genetic basis (1, 2). Probably an even
higher proportion of deafness among older children and
young adults is genetically influenced. However, the genetics
of human deafness is complex and heterogeneous. There are
at least 32 genetic forms of primary human deafness (i.e.,
deafness not secondary to some other disease), some of
which may themselves be heterogeneous (3). In addition to
genetic heterogeneity across affected families, deafness
among affected children in the same family may be due to
different genes, because deafpersons often marry each other.
Furthermore, some congenital forms of deafness are associ-
ated with severe abnormalities, sometimes leading to early
death and often to limited family size, so for these conditions
few families with more than one affected child are to be
found. Finally, many genetic forms of deafness are variable
in expression with incomplete penetrance. It is probably not
surprising, therefore, that heretofore no genes have been
mapped for primary human deafness.
Inherited low-frequency hearing loss (LFHLJ; no. 124900
in ref. 3) is an autosomal dominant, fully penetrant, senso-
rineural deafness originally described in an extended Costa
Rican kindred (4). In this kindred, low-tone deafness begins
at about age 10 and progresses by age 30 in males and females
to profound, irreversible, bilateral deafness involving all
frequencies. Impedance tests suggest normal stapedial re-
flexes and no mechanical damage (5). Tone decay and other
audiometric studies indicate normal retrocochlear function.
Speech development before onset of deafness is normal, as
are intelligence, fertility, and life expectancy.
Deafness in the Costa Rican kindred has been traced back
eight generations to Felix Monge, who was born in Costa
Rica in 1754. Testaments by Felix Monge and two of his
brothers indicate they were deafbut were born hearing. Felix
Monge's sibship was the seventh generation of their family in
Costa Rica. Their ancestors migrated to Costa Rica from
Jerez de la Frontera, Spain, about 1600. Most of the descen-
dants of Felix Monge still live near Cartago, Costa Rica. At
least 150 living adults from the family are informative for
linkage analysis. For this study, relatives were considered
informative if they either were diagnosed as deaf or were
older than age 25 years with no symptoms of hearing loss.
Ninety-nine of these informative relatives are included in this
report.
MATERIALS AND METHODS
Clinical evaluation of deafness was carried out by audiomet-
ric testing at the Centeno Guell Auditory Testing Facility in
San Jose, Costa Rica, as described (4, 5). Audiologic testing
was conducted in an Industrial Acoustics Corporation sound
chamber (model 400-SER). Interior noise levels did not
exceed 40 decibels, scale A. A clinical audiometer (Maico,
model MA-22) and a portable audiometer (Maico, model
MA-16) were used for pure tone and bone conduction testing
at 250 Hz through 8000 Hz. An impedance bridge (Teledyne,
model TA-3D) was employed for all tympanometry and
acoustic reflex testing. All audiometric equipment was cali-
brated before each period of testing. Before audiometric
evaluation, subjects were given otoscopic examinations to
determine the condition of their ear canals and then given the
opportunity to practice the required tasks. Pure tone and
bone conduction thresholds were measured using the modi-
fied Hughson-Westlake technique (6). Frequencies tested by
air conduction were 250, 500, 100, 2000, 3000, 4000, 6000, and
8000 Hz. Frequencies tested by bone conduction were 250,
500, 1000, 2000, 3000, and 4000 Hz.
Affected relatives older than age 25 in the kindred had pure
tone air conduction hearing threshold levels above 50 deci-
bels for all frequencies. Affected relatives younger than age
20 had mild to moderate hearing losses through 1000 Hz but
retained normal or near-normal thresholds for higher fre-
quencies. By age 30, thresholds were at severe levels across
the entire frequency range, leading to flat profound hearing
loss by age 40. Audiometric configurations for right and left
ears were similar, with all deafpersons affected bilaterally. A
minimal criterion for deafness in this kindred was a hearing
threshold greater than 50 decibels at 250 Hz and 500 Hz.
Relatives younger than age 25 with no apparent symptoms
were not included in the analysis.
Whole blood for 99 informative relatives was drawn into
acid citrate dextrose, lymphoblastoid cell lines were pre-
pared, and DNA was extracted using methods previously
described (7, 8). Southern hybridizations were carried out
according to standard procedures (9-11). Amplification and
electrophoresis of sequences containing microsatellite poly-
morphisms were carried out by methods described for these
loci (12-15). In Costa Rica, where 32p was not available,
sequences containing microsatellite polymorphisms were
amplified without labeled nucleotides, then electrophoresed
Abbreviations: lod, logarithm of odds; cM, centimorgan(s).
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Table 1. Polymorphisms on chromosome 5q linked to deafness in the Monge kindred
Locus Allele 6 Primer or probe/enzyme
FIBS 8 AAG GTG TTC TTT GCA TGT TCA CC
GTA ATG TGT TCT ATC TAG TTC AAC G
IL9 (SE9) 6 6.12 AGG TCC AGG CTA GCT CAT GT
CTA ATG CAG AGA TTT AGG GC
GRL 2 0.07 OB7/BcI I
DSS70 2 0.00 TP5E/TaqI
DSS210 (Mfdl22) 5 * ATG CAG AAT CTA CAA GGA CC
CTT TAA CAT CCT TTA ACA GC
DS207 (Mfd42) 3 * TTG GAA GCC TTA GGA AGT GC
AAG AAT TCT AGT TTC AAT ACC G
DSS119 (Mfd6) 4 0.14 TCC TAC CTT AAT TTC TGC CT
GCA GGT TGT TTA ATT TCG GC
DSS209 (Mfdll6) 8 OCTG CAG TAG AAA GGC AGA GT
TGC AGC ACC AAA CAC CAA GT
DSS22 3 0.11 J0205H-C/Msp I
6, Approximate distance between adjacent markers.
in 18-20% acrylamide gels, and stained with silver nitrate or
ethidium bromide.
Autosomal dominant transmission of deafness in the
Monge kindred was confirmed previously by segregation
analysis (4). Linkage was evaluated using LIPED (16), postu-
lating a rare autosomal dominant allele (q = 0.01) with
complete penetrance and no sporadic cases. Multipoint anal-
ysis was carried out using LINKAGE (17). Only genotypes that
were obtained explicitly for each person were included in the
linkage analysis: no inferred genotypes nor any haplotypes
were included in the statistical analysis.
RESULTS
Primer sequences or probe/enzyme combinations for mark-
ers on chromosome Sq are listed in Table 1 (see refs. 12-15
for allele frequencies). Order of markers and approximate
distances between adjacent markers are based on data from
CEPH (ref. 13; unpublished data) and from the Monge
kindred. Relative orders of D5S210 vs. D5S207, of D5S119
vs. D5S209, and of GRL vs. DS570 cannot be determined
from our data so far.
Coinheritance of deafness with chromosome 5q markers in
the Monge kindred is shown in Fig. 1. Haplotypes and
genotypes for deceased persons are indicated in Fig. 1 but
were not included in the statistical analysis. Two-point log-
arithm of odds (lod) scores for linkage of deafness to markers
in this region are indicated in Table 2. Multipoint analysis of
the 14-cM interval defined by IL9 and D5S210/D5S207
strongly suggests that the LFHLI gene is between these
markers. The maximum lod score for a gene proximal to IL9
is 9.95; the maximum lod score for a gene within the interval
is 12.42; the maximum lod score for a gene distal to D5S207/
DSS2J0 is 7.46. The maximum lod score within the interval
occurs =5 cM distal to IL9, which corresponds to a locale
slightly proximal to GRL.
Table 2. Maximum two-point lod scores (Z ), maximum
likelihood recombination fractions (6), and 95% confidence
intervals for 6 for linkage of deafness to chromosome 5 markers
95% confidence
Marker Z 6 interval
FIBS 6.63 0.06 (0.01, 0.12)
IL9 13.55 0.06 (0.01, 0.12)
GRL 2.65 0.10 (0.02, 0.30)
DSD210/D5S207 7.50 0.13 (0.05, 0.31)
Seven persons with informative recombination events
place the deafness gene LFHL1 between lL9 and GRL. In
Fig. 1, persons A, C, E, and F indicate that LFHLI is
proximal to GRL; B, D, and G indicate that LFHLI is distal
to IL9.
DISCUSSION
Deafness in this kindred appears to be determined by a gene
between 1L9 and GRL, an interval of -7 cM. Because
LFHLI is primary deafness, with no associated abnormali-
ties, the normal function of the LFHLI gene may be specific
to hearing. Other occurrences of sensorineural deafness,
whether inherited or apparently sporadic, may be due to
other mutations at the LFHLI locus (3, 18). Linkage infor-
mation from the Monge kindred will permit this hypothesis to
be tested in other families. The LFHLI gene appears not to
be identical to the gene for Treacher Collins syndrome, a
complex mandibulofacial disorder sometimes involving deaf-
ness, which maps distal to GRL and, hence, distal to the
LFHLI gene (19, 20).
Physical maps of human chromosome 5q indicate that IL9
and GRL map to 5q31 (21, 22). Genes coding for early growth
response (EGRI), antigen CD14, and endothelial growth
factor (FGFA) are located between IL9 and GRL (21). This
region of human chromosome 5q is homologous to a portion
of mouse chromosome 11. The mouse shaker-2 locus maps to
this region, but outside the interval defined by Sparc and the
interleukin loci (23). If genes in this region are in the same
order in mouse and humans, the shaker-2 locus would be
outside the critical region of linkage for LFHLI (21).
The LFHLI gene can be further localized by mapping
deafness in the Monge kindred relative to additional markers
in this region of chromosome 5q. Given that -150 informa-
tive relatives have agreed to participate (of whom 99 have
been sampled thus far), this large kindred offers the potential
of mapping this gene to a resolution of -1 cM. Coding
sequences in close physical proximity to markers showing no
recombination with LFHLI can then be investigated.
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